Recall Reporting in Canada: 24-Hour Notice and Initial and Final Reports
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Under section 63.2 of the Medical Devices Regulations, manufacturers and importers must submit an initial notice to Health Canada within 24 hours after deciding to conduct a recall in Canada. Under GUI-0054, the initial recall report must be submitted no later than the start of the recall, and the final recall report must be submitted within 30 calendar days after the completion of the recall (section 65).
- The 24-hour clock runs from the decision to conduct a recall in Canada, not from the start of execution.
- Three reporting points run independently: the 24-hour notice, the initial recall report (section 64), and the final recall report within 30 calendar days of completion (section 65).
- Section 65.1 allows a manufacturer to permit the importer to prepare and submit recall information and documents on its behalf, where the information and documents that each must submit are completely identical.
- Section 63 exempts retailers and healthcare institutions that distribute devices within their facilities from sections 63.2, 64 and 65, but this does not exempt the recall execution itself.
- GUI-0054 clarifies that non-reportable recalls should nonetheless be handled following the process for reportable recalls.
- The recall procedure should be prepared according to GUI-0054, using form FRM-0360 for initial and final reports.
2. Legal basis
The recall reporting regime combines statutory timelines in the Medical Devices Regulations with the operational expectations set out in Health Canada’s recall guidance GUI-0054. The table below lists the provisions relied on in this article, with their dates and sources.
| Regulation / document | Provision | Date | Source |
| Medical Devices Regulations | Section 63.1: the condition for the application of sections 63.2, 64 and 65 (the device may present a danger to health or may cause serious injury) | SOR/98-282 | Justice Laws |
| Medical Devices Regulations | Section 63.2: notification within 24 hours after deciding to conduct a recall in Canada | Same | Same |
| Medical Devices Regulations | Section 63: retailers and healthcare institutions that distribute devices within their facilities are not subject to sections 63.2, 64 and 65 | Same | Same |
| Medical Devices Regulations | Section 64: initial recall report | Same | Same |
| Medical Devices Regulations | Section 65: final recall report (within 30 calendar days after the completion of the recall) | Same | Same |
| Medical Devices Regulations | Section 65.1: the manufacturer may permit the importer to prepare and submit on its behalf (where the content is completely identical) | Same | Same |
| GUI-0054 (recall guidance) | 24-hour notice; initial report no later than the start of the recall; final report within 30 calendar days after completion of the recall; form FRM-0360 | Current | canada.ca |
3. Expert insights
Recall reporting is where the tightest clock in the Canadian post-market system sits. The insights below unpack the four points that determine whether a recall notification lands on time and with the right division of labour.
Insight 1: the 24-hour clock starts from the “decision”, not from execution.
According to the interpretation of section 63.2 in GUI-0054, the initial notice must be submitted within 24 hours after the decision is made to conduct a recall in Canada. This means the company’s problem confirmation, its decision-making, and the drafting of the notice must all be compressed into those 24 hours; the company cannot wait until customers have been notified before reporting to Health Canada.
Insight 2: the three reporting points are independent of each other and are often confused.
Decision to recall → within 24 hours, submit the initial notice (section 63.2); at or before the start of the recall, submit the initial recall report (section 64, expressed in GUI-0054 as “on or before starting the recall”); within 30 calendar days after the completion of the recall, submit the final recall report (section 65). Three timers start at three different moments, and each needs its own owner and template.
Insight 3: section 65.1 provides a channel for submission by the importer on the manufacturer’s behalf.
Under section 65.1, notwithstanding sections 64 and 65, the manufacturer of a device may permit the importer of the device to prepare and submit, on the manufacturer’s behalf, the information and documents related to the recall, on the condition that the information and documents that the manufacturer and the importer must submit are completely identical. This provision supplies the legal basis for the division of labour between a foreign manufacturer and its Canadian importer.
Insight 4: section 63 excludes two categories of parties, but not recall execution itself.
Under section 63, sections 63.2, 64 and 65 do not apply to retailers, nor to healthcare institutions that distribute a device for use within their own facilities. GUI-0054 further explains that a non-reportable recall should nonetheless be executed following the process used for reportable recalls. The reporting exemption therefore narrows the notification duty only; the operational discipline of a recall remains.
4. Practical recommendations
- Build a “decision to recall → 24-hour countdown” process into the quality system, starting automatically from the decision date.
- Assign owners and templates separately to the three reporting points: the 24-hour notice, the initial report, and the final report (30 calendar days).
- Where a foreign manufacturer works with a Canadian importer, document the submission arrangement in writing under section 65.1 and confirm that the content is completely identical.
- Prepare the recall procedure according to GUI-0054, including progress reports where Health Canada requires them.
- Submit using the FRM-0360 form series (initial and final) and retain proof of submission.
5. Verification checklist
- □ A “decision to recall → 24-hour” countdown process has been pre-configured
- □ Owners and templates have been set up separately for the three reporting points
- □ The initial report is scheduled for submission at or before the start of the recall
- □ The final report is scheduled for submission within 30 calendar days after completion of the recall
- □ The submission arrangement between the foreign manufacturer and the importer has been documented in writing under section 65.1
- □ FRM-0360 submission records have been archived
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Canadian market. Our team manages Health Canada Medical Device Licence and MDEL applications, prepares risk-classified dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us